The global Orthobiologics Market is valued at $6.56 billion in 2024 and is projected to reach a value of $10.4 billion by ...
Regenerative medicine stands as one of the most promising therapeutic approaches of the 21st century, offering groundbreaking ...
The US Food and Drug Administration (FDA) has granted 510(k) clearance to the BioCharge Autobiologic Matrix, a bioresorbable synthetic implant developed by startup Atreon Orthopedics to enhance ...
The global biosurgery market is projected to grow at a CAGR of 5% from 2025 to 2030. This growth is driven by the increasing prevalence of chronic conditions necessitating surgical interventions, ...
A new study from the University of Ottawa’s Faculty of Medicine sheds light on a potential breakthrough in treating muscle ...